BETA BIONICS INC (BBNX) Stock Analyst Ratings
NASDAQ:BBNX - US08659B1026 - Common Stock
18.53 USD
-0.18 (-0.96%)
ChartMill assigns a Buy % Consensus number of 84% to BBNX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.14. This target is 30.28% above the current price.
BBNX was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BBNX.
In the previous month the buy percentage consensus was at a similar level.
BBNX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-30 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-30 | Baird | Maintains | Neutral -> Neutral |
| 2025-06-16 | Truist Securities | Initiate | Buy |
| 2025-05-30 | Wolfe Research | Initiate | Outperform |
| 2025-05-30 | Goldman Sachs | Initiate | Neutral |
| 2025-02-24 | Leerink Partners | Initiate | Outperform |
| 2025-02-24 | Lake Street | Initiate | Buy |
| 2025-02-24 | Stifel | Initiate | Buy |
| 2025-02-24 | Piper Sandler | Initiate | Overweight |
| 2025-02-20 | Ladenburg Thalmann | Initiate | Buy |
| 2025-02-20 | Baird | Initiate | Neutral |